Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Telomerase in anti-tumor response (CROSBI ID 127493)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Batinac, Tanja ; Zamolo, Gordana ; Hadžisejdić, Ita Telomerase in anti-tumor response // Medical hypotheses, 68 (2007), 1; 128-130-x

Podaci o odgovornosti

Batinac, Tanja ; Zamolo, Gordana ; Hadžisejdić, Ita

engleski

Telomerase in anti-tumor response

Telomerase is responsible for maintaining the length of telomeres at the end of chromosomes. It protects chromosomes from degradation and aberrant recombination during replication prolonging the life span of the cell. Human telomerase reverse transcriptase (hTERT) is highly expressed in >85% of cancer cells but its expression is repressed in most human somatic cells. It has been shown that expression of human telomerase reverse transcriptase greatly extends the life span of both human CD8+ and CD4+ T cells during activation and proliferation. hTERT-positive tumor cells can induce cytotoxic T lymphocyte response as well as T helper response. On the other hand, it is possible that cytotoxic immune response to hTERT-positive tumor cells can cause autoimmune reaction directed against T cells in a tumor bearing host. This could lead to apoptosis and decreased number of activated T cells and insufficient anti-tumor immunity resulting in tumor progression.

telomerase; anti-tumor response

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

68 (1)

2007.

128-130-x

objavljeno

0306-9877

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost